Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shruthi Kodad

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Influenza and Other Respiratory Viruses|April 23, 2020
Covid-19 and NamastePrashanth Kulkarni, Shruthi Kodad, Manjappa Mahadevappa
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 24, 2025
Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myelomaYoussef Elemary, Waleed Sabry, Julie Stakiw, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2023
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple MyelomaJulie Stakiw, Shruthi Kodad, Richard LeBlanc, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Influenza and Other Respiratory Viruses|April 23, 2020
Covid-19 and NamastePrashanth Kulkarni, Shruthi Kodad, Manjappa Mahadevappa
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 24, 2025
Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myelomaYoussef Elemary, Waleed Sabry, Julie Stakiw, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2023
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple MyelomaJulie Stakiw, Shruthi Kodad, Richard LeBlanc, et al.
Pageof 1